Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2015) Silvio E. Inzucchi et al.   DIABETOLOGIA

Polypharmacy in the Aging Patient

(2015) Athanase Benetos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects

(2014) J. van der Leeuw et al.   EUROPEAN HEART JOURNAL

Effect of Patients’ Risks and Preferences on Health Gains With Plasma Glucose Level Lowering in Type 2 Diabetes Mellitus

(2014) Sandeep Vijan et al.   JAMA Internal Medicine

Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes

(2013) Tanika N. Kelly   ANNALS OF INTERNAL MEDICINE

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Global estimates of diabetes prevalence for 2013 and projections for 2035

(2013) L. Guariguata et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis

(2013) D. Nitsch et al.   BMJ-British Medical Journal

Participatory Surveillance of Hypoglycemia and Harms in an Online Social Network

(2013) Elissa R. Weitzman et al.   JAMA Internal Medicine

Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring

(2012) Thomas A. Gerds et al.   STATISTICS IN MEDICINE

Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial

(2011) M. Woodward et al.   DIABETES CARE

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

(2011) S. Zoungas et al.   DIABETOLOGIA

Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

(2010) J. Calles-Escandon et al.   DIABETES CARE

The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial

(2010) S. Zoungas et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

(2010)   LANCET

Severe Hypoglycemia and Risks of Vascular Events and Death

(2010) Sophia Zoungas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

(2010) David M Kent et al.   Trials

Intensive glucose control and macrovascular outcomes in type 2 diabetes

(2009) F. M. Turnbull et al.   DIABETOLOGIA

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

(2009) Kausik K Ray et al.   LANCET

Paget's Disease of the Mandible

(2008) Mayank B. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE